Cargando…
DLL3 regulates Notch signaling in small cell lung cancer
Tumor heterogeneity plays a critical role in tumor development and response to treatment. In small-cell lung cancer (SCLC), intratumoral heterogeneity is driven in part by the Notch signaling pathway, which reprograms neuroendocrine cancer cells to a less/non-neuroendocrine state. Here we investigat...
Autores principales: | Kim, Jun W., Ko, Julie H., Sage, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722452/ https://www.ncbi.nlm.nih.gov/pubmed/36483011 http://dx.doi.org/10.1016/j.isci.2022.105603 |
Ejemplares similares
-
DLL3: an emerging target in small cell lung cancer
por: Owen, Dwight H., et al.
Publicado: (2019) -
Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007) -
DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail
por: Furuta, Megumi, et al.
Publicado: (2019) -
NOTCH2/NOTCH3/DLL3/MAML1/ADAM17 signaling network is associated with ovarian cancer
por: Jia, Dongyu, et al.
Publicado: (2019) -
Maintenance of Bone Homeostasis by DLL1‐Mediated Notch Signaling
por: Muguruma, Yukari, et al.
Publicado: (2017)